Form 8-K - Current report:
SEC Accession No. 0001437749-25-014815
Filing Date
2025-05-06
Accepted
2025-05-06 17:00:35
Documents
16
Period of Report
2025-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K omer20250506_8k.htm   iXBRL 8-K 25292
2 EXHIBIT 99.1 ex_812896.htm EX-99.1 13317
7 ex_812896img001.jpg GRAPHIC 3578
  Complete submission text file 0001437749-25-014815.txt   186781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA omer-20250506.xsd EX-101.SCH 3578
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20250506_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250506_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250506_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT omer20250506_8k_htm.xml XML 2866
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 25918136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)